KLK3 and prostate carcinoma: While both urologists and PCPs were highly aware of US Preventive Services Task Force guidelines, PCPs were much less likely than urologists to believe in the value of PSA testing or the role of early detection to prevent prostate cancer–related mortality (2 [6.5%] vs 24 [75.0%], respectively).